BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu J, Fu XQ, Zhou W, Yu HG, Yu JP, Luo HS. LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway. World J Gastroenterol 2011; 17(2): 181-190 [PMID: 21245990 DOI: 10.3748/wjg.v17.i2.181]
URL: https://www.wjgnet.com/1007-9327/full/v17/i2/181.htm
Number Citing Articles
1
Jennifer W. Harris, Tianyan Gao, B. Mark Evers. Intestinal Tumorigenesis2015; : 101 doi: 10.1007/978-3-319-19986-3_4
2
Qianhui Sun, Jingyuan Wu, Guanghui Zhu, Tingting Li, Xiaoyu Zhu, Baoyi Ni, Bowen Xu, Xinyi Ma, Jie Li. Lactate-related metabolic reprogramming and immune regulation in colorectal cancerFrontiers in Endocrinology 2023; 13 doi: 10.3389/fendo.2022.1089918
3
Ahmad R. Safa, Karen E. Pollok. Targeting the Anti-Apoptotic Protein c-FLIP for Cancer TherapyCancers 2011; 3(2): 1639 doi: 10.3390/cancers3021639
4
Zhen Lu, Aman Xu, Xiao Yuan, Kaiwei Chen, Likun Wang, Tao Guo. Anticancer effect of resibufogenin on gastric carcinoma cells through the phosphoinositide 3‑kinase/protein kinase�B/glycogen synthase kinase 3β signaling pathwayOncology Letters 2018;  doi: 10.3892/ol.2018.8979
5
CHENFEI ZHOU, JUN JI, MIN SHI, LIU YANG, YINGYAN YU, BINGYA LIU, ZHENGGANG ZHU, JUN ZHANG. Suberoylanilide hydroxamic acid enhances the antitumor activity of oxaliplatin by reversing the oxaliplatin-induced Src activation in gastric cancer cellsMolecular Medicine Reports 2014; 10(5): 2729 doi: 10.3892/mmr.2014.2548
6
Leimarembi Devi Naorem, Mathavan Muthaiyan, Ishita Bhattacharyya, Dinakara Rao Ampasala, Amouda Venkatesan. A Theranostic and Precision Medicine Approach for Female-Specific Cancers2021; : 31 doi: 10.1016/B978-0-12-822009-2.00002-9
7
Olga Kersy, Shelly Loewenstein, Nir Lubezky, Osnat Sher, Natalie B. Simon, Joseph M. Klausner, Guy Lahat. Omental Tissue-Mediated Tumorigenesis of Gastric Cancer Peritoneal MetastasesFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01267
8
Guoqiong Lei, Sushun Liu, Xin Yang, Chao He, Ravindran Caspa Gokulan. TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer CellCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/8870907
9
Duncan Ayers, Alessandro Nasti. Utilisation of Nanoparticle Technology in Cancer ChemoresistanceJournal of Drug Delivery 2012; 2012: 1 doi: 10.1155/2012/265691
10
Guiqin Hou, Qi Zhao, Mengying Zhang, Tianli Fan, Mingyue Liu, Xiaojing Shi, Yandan Ren, Yang Wang, Jiaxu Zhou, Zhaoming Lu. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinomaBiomedicine & Pharmacotherapy 2018; 106: 1348 doi: 10.1016/j.biopha.2018.07.075
11
Hui Zhang, Yidan Lin, Minxue Zhuang, Lin Zhu, Yongmei Dai, Mengbo Lin. Screening and identification of CNIH4 gene associated with cell proliferation in gastric cancer based on a large-scale CRISPR-Cas9 screening database DepMapGene 2023; 850: 146961 doi: 10.1016/j.gene.2022.146961
12
Feng Qiu, Chun‐hua Shi, Jun Zheng, Yu‐bin Liu. Periostin Mediates the Increased Pro‐Angiogenic Activity of Gastric Cancer Cells under Hypoxic ConditionsJournal of Biochemical and Molecular Toxicology 2013; 27(7): 364 doi: 10.1002/jbt.21498
13
R. Reilly, M. S. Mroz, E. Dempsey, K. Wynne, S. J. Keely, E. F. McKone, C. Hiebel, C. Behl, J. A. Coppinger. Targeting the PI3K/Akt/mTOR signalling pathway in Cystic FibrosisScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06588-z
14
Yue Song, Zhao-xia Li, Xi Liu, Rui Wang, Li-wei Li, Qingyu Zhang. The Wnt/β-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylationTumor Biology 2017; 39(7): 101042831771261 doi: 10.1177/1010428317712617
15
Yi-Jun Wang, Xiao-Li Xie, Hong-Qun Liu, Hui Tian, Xiao-Yu Jiang, Jiu-Na Zhang, Sheng-Xiong Chen, Ting Liu, Shu-Ling Wang, Xue Zhou, Xiao-Xu Jin, Shi-Mao Liu, Hui-Qing Jiang. Prostaglandin F<sub>2α</sub> synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F<sub>2α</sub>-dependent and F<sub>2α</sub>-independent mechanismWorld Journal of Gastroenterology 2023; 29(39): 5452-5470 doi: 10.3748/wjg.v29.i39.5452